Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Craniocerebral Trauma

2-amino-5-phosphonovalerate has been researched along with Craniocerebral Trauma in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Craniocerebral Trauma: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santhakumar, V1
Bender, R1
Frotscher, M1
Ross, ST1
Hollrigel, GS1
Toth, Z1
Soltesz, I1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Craniocerebral Trauma

ArticleYear
Granule cell hyperexcitability in the early post-traumatic rat dentate gyrus: the 'irritable mossy cell' hypothesis.
    The Journal of physiology, 2000, Apr-01, Volume: 524 Pt 1

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Bicuc

2000